Safety and immunogenicity of a novel quadrivalent subunit influenza vaccine in animal models
Background: Compared with trivalent influenza vaccines, quadrivalent influenza vaccines are expected to provide wider protection against influenza B virus infections. We developed a novel quadrivalent subunit influenza vaccine which was distinct from the influenza vaccines available on the market in...
Main Authors: | Huayue Ye, Siyue Jia, Yuhui Zhang, Jingxin Li, Fengcai Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1737456 |
Similar Items
-
Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older
by: David P. Greenberg, et al.
Published: (2017-09-01) -
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6–35 months in China
by: Yuemei Hu, et al.
Published: (2020-07-01) -
Preclinical study of immunogenicity of adjuvanted quadrivalent subunit influenza vaccine
by: I. V. Krasilnikov, et al.
Published: (2022-07-01) -
Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study
by: Indraneel Basu, et al.
Published: (2022-01-01) -
Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India
by: Sharad Agarkhedkar, et al.
Published: (2019-04-01)